Type VI secretion system: Central regulator of antimicrobial resistance dynamics via indirect mechanisms
Microbiological Research · 2026-10 · 311 · 128574
DOI: 10.1016/j.micres.2026.128574 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbiological Research, 2026-10. Verfasst von Ziyun Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Maternal and Child Health Care Hospital affiliated to Qingdao University, Jinan, China. Electronic address: liziyun@qdu.edu.cn. Hauptthemen laut MEDLINE: Type VI Secretion Systems, Gram-Negative Bacteria, Drug Resistance, Multiple, Bacterial, Drug Resistance, Bacterial. Die Arbeit nennt 97 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Shandong Provincial Health Commission.
Abstract (Originalsprache)
Multidrug resistance (MDR) in bacteria poses a significant global threat to public health. Elucidating the core molecular regulatory mechanisms underlying MDR is crucial for developing novel intervention strategies. In Gram-negative bacteria, the phage-derived Type VI Secretion System (T6SS) functions as a versatile "molecular weapon". Beyond its classical role in interbacterial antagonism, T6SS acts as a key indirect regulatory hub for modulating bacterial antimicrobial resistance (AMR) in a strain-specific and environment-dependent manner. Although T6SS does not directly participate in the expression of antibiotic resistance genes (ARGs) or the catalytic activity of AMR-related enzymes, it profoundly influences the development and dissemination of AMR across strains and species through multiple indirect mechanisms. This review systematically analyzes four core T6SS-mediated mechanisms: (1) secretion of AMR-associated effectors and biofilm modulation to establish resistant phenotypes; (2) formation of synergistic regulatory networks with biofilm development, oxidative stress response, efflux pumps, and other secretion systems, which specifically enhances bacterial antibiotic tolerance (distinct from antibiotic resistance phenotypes); (3) acceleration of horizontal gene transfer (HGT) of ARGs through natural transformation, plasmid conjugation, and outer membrane vesicle (OMV)-mediated transport; (4) targeted interbacterial killing enabling antimicrobial-resistant strains to overcome colonization resistance, gain ecological advantages, and exacerbate clinical infections. Building on this framework, novel anti-AMR strategies targeting T6SS are outlined, including direct disruption of T6SS assembly and function, interference with upstream regulators (e.g., quorum sensing), optimization of CRISPR-Cas gene editing, and engineered T6SS-targeted delivery platforms. By dissecting the T6SS-driven AMR network and its clinical translational potential, this review provides a foundation for designing next-generation therapies to reverse AMR and block ARG transmission and also discusses existing bottlenecks limiting the clinical translation of T6SS-targeted therapies, while identifying critical future research directions such as deciphering species-specific mechanisms and enhancing targeted delivery efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Maternal and Child Health Care Hospital affiliated to Qingdao University, Jinan, China. Electronic address: liziyun@qdu.edu.cn.
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
- Department of clinical laboratory, The Second Qilu Hospital of Shandong University, Jinan, China. Electronic address: lin790832736@163.com.
- Shandong Provincial Maternal and Child Health Care Hospital affiliated to Qingdao University, Jinan, China. Electronic address: liyanxj@sina.com.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Shandong Provincial Health Commission
- Medical and Health Science and Technology Development Project of Shandong Province
Zitieren
APA
Li, Z., Huang, J., Li, Y., Cao, F., Gao, X., Lin, Y., & Li, Y. (2026). Type VI secretion system: Central regulator of antimicrobial resistance dynamics via indirect mechanisms. Microbiological Research, 311, 128574. https://doi.org/10.1016/j.micres.2026.128574
Vancouver
Li Z, Huang J, Li Y, Cao F, Gao X, Lin Y, et al. Type VI secretion system: Central regulator of antimicrobial resistance dynamics via indirect mechanisms. Microbiological Research. 2026;311:128574. doi:10.1016/j.micres.2026.128574
BibTeX
@article{Li2026,
author = {Li, Ziyun and Huang, Jingjie and Li, Yonghao and Cao, Feiyu and Gao, Xueyan and Lin, Yueke and Li, Yan},
title = {Type VI secretion system: Central regulator of antimicrobial resistance dynamics via indirect mechanisms},
journal = {Microbiological Research},
year = {2026},
volume = {311},
pages = {128574},
doi = {10.1016/j.micres.2026.128574}
}
EUVIMED